Navigation Links
Cytel Hires Biopharmaceutical Development Veteran Jim Baker to Support Expansion of its Clinical Research Offerings
Date:3/18/2011

CAMBRIDGE, Mass., March 18, 2011 /PRNewswire/ -- Cytel Inc., premier provider of clinical trial design and implementation services and software, proudly announced today the addition of pharmaceutical and biotech industry veteran Jim Baker as Vice President, Clinical Research Services.

Over his 28 year career, Baker has demonstrated biopharmaceutical development leadership at some of the world's top pharmaceutical, biotech and clinical research firms including Amgen®, Wyeth® and Parexel®. Most recently Baker served as Senior Director of Study Standards Implementation at Millennium®.

Jim Baker is respected not only for his cross-functional experience spanning both development planning and clinical operations, but also equally for his in-depth trial data management knowledge.

Cytel CEO Ranganath Nayak remarked: "Jim's talent and track record are a precise match for Cytel's expanding line of innovative Clinical Research Services. Our customers will be happy that we have someone who has walked many a mile in their shoes and understands not only what their needs are but also how best to align Cytel's capabilities with those needs."

Baker has officially assumed his new position and it is our distinct pleasure to welcome him as the newest member of the Cytel management team.

About Cytel

Cytel Inc. is a leading provider of clinical research services and trial design and analysis software primarily for the biopharmaceutical and medical device development markets.

Cytel pioneered the statistical science of adaptive clinical trials and has designed more validated adaptive trials than any other service provider. Cytel software is used by 47 of the top 50 biopharmaceutical companies to d
'/>"/>

SOURCE Cytel Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cytel Announces Compass® - The Only Professional Adaptive Trial Software Package for Bayesian or Frequentist Dose-Finding Studies
2. Cytel Signs Cooperative Research And Development Agreement With FDA Center for Devices and Radiological Health (CDRH)
3. Cytels Clinical Innovation Experts Cyrus Mehta and Judith Quinlan Reveal Latest Adaptive Trial Successes at 44th Annual DIA Meeting
4. Judith Quinlan Joins Cytel as Vice President, Adaptive Trials
5. Accuray Hires Chief Marketing Officer
6. PharMEDium Hires Thomas W. Rasnic as Vice President, Quality, Regulatory Affairs and Research and Development
7. Pharmaceutical Institute Hires Nathan Pienkowski, Ph.D., to Head Instructional Design
8. Oxford Finance Corporation Hires Debbie Baker to Support Life Science Business Development in Western North America
9. Accuray Hires General Manager for the Asia Pacific Region
10. Diplomat Specialty Pharmacy Launches Diplomat University - Hires Jennifer Hagerman, PharmD, Pharmacy Professor
11. Prime Therapeutics Hires Peter Wickersham, Senior Vice President Cost of Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... -- Commonwealth Cornerstone Group (CCG) today announced the completion of an ... help fund the expansion and consolidation of healthcare services provided ... . PHN is the largest federally qualified ... is the largest employer in Sharon,s ... Currently, PHN Sharon offers scattered services out of ...
(Date:12/24/2014)... , Dec. 24, 2014 Soligenix, ... late-stage biopharmaceutical company developing products that address unmet ... and biodefense, announced today that on December 24, ... offering. The Company raised approximately $2.3 ... intends to use the net proceeds from the ...
(Date:12/24/2014)... Mich. , Dec. 24, 2014  Diplomat Pharmacy, ... independent specialty pharmacy, is proud to announce Jennifer ... quality at Diplomat, will take office as the president ... The formal induction ceremony will take place Feb. 28, ... will be held at the Renaissance Center in ...
Breaking Medicine Technology:Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 2Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 3Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3
... - Positive data on subcutaneous administration show potential ... CHICAGO, June 04, 2007 /PRNewswire-FirstCall/ -- Millennium,Pharmaceuticals, Inc. ... the market-leading therapy for patients with,multiple myeloma (MM) ... data include results from a Phase II trial ...
... CHICAGO, June 04, 2007 /PRNewswire/ -- GlaxoSmithKline ... of pazopanib in,advanced or metastatic renal cell ... (STS). These trials were presented at the,43rd ... Clinical Oncology,(ASCO) in Chicago. The results observed ...
Cached Medicine Technology:New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 2New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 3New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 4New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 5New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 6New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 7GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 2GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 3GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 4GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 5GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 6GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 7
(Date:12/26/2014)... (PRWEB) December 26, 2014 India Network ... insurance in the USA, announced today a new version ... members in choosing the right plan for their visiting ... complexity out of the selection process when choosing an ... age group with only a few clicks. Many elderly ...
(Date:12/25/2014)... This is a professional and in-depth study on ... a focus on the Chinese market. The report provides ... manufacturers and is a valuable source of guidance and ... This report provides a basic overview of the industry ... part, the report presents the company profile, product specifications, ...
(Date:12/25/2014)... three months the trends for evening dresses shift ... one of the hottest styles in the next few months.” ... releases 26 A-line sweetheart evening dresses, and announces the availability ... are trying our best to help a lady to show ... affordable prices, we provide discounted delivery costs to our customers ...
(Date:12/25/2014)... BambooFlooringChina.com sells many bamboo products and the business is ... company announces big discounts on its bamboo mats , ... is the world’s leader in bamboo flooring. According to ... 20, 2015. , The bamboo mats are made from ... All the bamboo strips for the mats are boiled ...
(Date:12/25/2014)... Dec. 25, 2014 (HealthDay News) -- The risk of ... holidays, so you need to be extra cautious, an ... we see a significant increase in patients coming in ... the Suffolk County Volunteer Firefighters Burn Center of Stony ... should be full of joy, but if not careful, ...
Breaking Medicine News(10 mins):Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 2Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:Don't Let Burns Mar Your Holidays 2
... Bill Includes Three Provisions That Protect Patient Access ... The U.S. Senate and,House of Representatives have voted ... 6331, the Medicare Improvements for Patients and Providers ... executive vice president and,CEO of the National Community ...
... executives within the accounting and finance, advertising/marketing, ... human resources, legal, medical device/pharmaceutical, military transition ... industries. With offices nationwide and its expansion ... for Fortune 100+ companies, as well as ...
... company who pioneered web-based vendor access services for healthcare facilities, ... representatives operate more efficiently and increase facility safety. , ... ... 2008 -- VendorClear™, the company who pioneered web-based vendor access ...
... Friday, July 18, 2008 the young,scientists at Happy Faces ... partaking in Cornell University,s Lost Lady Bug Project. They ... and releasing,ladybugs. Memorial Field is located off Valley Parkway ... River. Their findings will be,sent to Cornell,s Entomology department ...
... 15 , WHAT: SheKnows ( http://www.SheKnows.com ) partners with DKMS ... largest bone marrow donor ... ( http://www.helpgiovanniguglielmo.org ) to promote awareness of ... to International Bone Marrow ...
... Global Pain Management Franchise, MADISON, N.J., July ... (NYSE: WYE ), announced today that it ... over-the-counter,heat wrap, from Procter & Gamble (NYSE: ... the next few months., ThermaCare fits Wyeth ...
Cached Medicine News:Health News:Lucas Group Celebrates Its 38th Anniversary 2Health News:VendorClear™ Introduces Revolutionary Products for Healthcare Facilities and Vendor Representatives 2Health News:Lakewood Childcare Participates in Ladybug Hunt 2Health News:SheKnows to Launch Bone Marrow Awareness Campaign and Add 50,000 New Donors 2Health News:Wyeth Consumer Healthcare Signs Agreement to Purchase ThermaCare from Procter & Gamble 2Health News:Wyeth Consumer Healthcare Signs Agreement to Purchase ThermaCare from Procter & Gamble 3Health News:Wyeth Consumer Healthcare Signs Agreement to Purchase ThermaCare from Procter & Gamble 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: